Cadrenal Therapeutics Inc (CVKD)
0.465
+0.01
(+2.31%)
USD |
NASDAQ |
May 02, 16:00
0.4649
0.00 (0.00%)
After-Hours: 20:00
Cadrenal Therapeutics Cash from Financing (TTM): 11.90M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 11.90M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
11.90M
Minimum
Dec 2023
11.90M
Maximum
Dec 2023
11.90M
Average
11.90M
Median
Dec 2023
Cash from Financing (TTM) Benchmarks
Tenax Therapeutics Inc | 13.57M |
Syra Health Corp | 6.051M |
Relmada Therapeutics Inc | -0.0985M |
Minerva Neurosciences Inc | 19.60M |
Adverum Biotechnologies Inc | 0.069M |